AR
EN
Patient monitoring
meaningful innovation masthead

Continuous monitoring and measurements. Advanced clinical insight.

Philips IntelliVue with
Masimo rainbow SET™

Philips patient monitoring with Masimo technology provides noninvasive, continuous hemoglobin monitoring you can rely on – at the point of care. Maintain consistent visibility on your patient's condition between invasive hemoglobin samples. Streamline workflows and drive down costs while providing clinically proven patient monitoring across care settings.

Measure value with Masimo technology


Philips lntelliVue with Masimo rainbow SET expands clinical capabilities without burdening operations.

Provides accurate hemoglobin measurement

Provides accurate hemoglobin measurement

Stay informed about changes in your patient's hemoglobin - in between invasive blood samples.

Works with your IT

Works with your IT

Capture additional continuous data and feed it securely to the EMR via existing infrastructure.

Works with your IT

Supports your hospital's workflows

View trends, key measurement parameters and more, at the bedside and during transport.

SCCM 2019: Society of Critical Care Medicine

February 17th – February 19th | San Diego Convention Center, San Diego, CA | Philips Booth: 1319

Noninvasive measurement technology – in clinical practice


Peer reviews have found that using SpHb® monitoring in conjunction with invasive blood sampling can deliver value in the ER, OR, and during transport.

Stat icon 1

In low blood loss surgical applications

Reduces unnecessary transfusions

>87% reduction in transfusion frequency

(from 4.5% to 0.6%)1

 

>90% reduction in average units transfused (from 0.1 to 0.01 units per patient)1

Stat icon 2

In high blood loss surgical applications

Reduces unnecessary transfusions

> 73% to 32% reduction in the percentage of patients receiving 3 or more units2*

 

> 47% reduction in average units transfused (1.9 to 1.0 per patient)2*

Initiate timely transfusions when transfusions are needed

*

معلومات الاتصال

* هذا الحقل مطلوب

*
*
*
*
*
*
*
*
*

من خلال تحديد سبب التواصل بك بإمكاننا توفير خدمة أفضل لك.

We work with partners and distributors who may contact you about this Philips product on our behalf.

*
*

Final CEE consent

Read more about Philips and Masimo

The partnership

The partnership

 

Philips and Masimo have teamed up to create the future of measurements and monitoring.

Rainbow SET Technology

rainbow SET measurement technology

 

Continuous visibility of key patient measurement parameters.

References


Masimo clinical claims are referenced on this web page. All studies available at www.masimo.com/evidence/featured-studies/feature/

(1) Transt . 2014. 5:237.DOl:10.4172/2155-9864.1000237

(2) Awada WN et al J Clin Mon it Comput. DOI 10.1007/s10877-015-9660-4.

*Study Protocol: In each group, if researchers noted SpHb trended downward below 10 g/dl, a red blood cell transfusion was started and continued until SpHb** trended upward above 10 g/dl. The transfusion threshold of 10 g/dl was predetermined by the study protocol and may not be appropriate for all patients. Blood sampling was the same for the control and test group. Arterial blood was drawn from a 20 gauge radial. **SpHb monitoring is not intended to replace lab testing. Blood samples should be analyzed by lab instruments prior to clinical decision making.

You are about to visit a Philips global content page

Continue

You are about to visit the Philips USA website.

أقر بذلك

You are about to visit a Philips global content page

Continue

You are about to visit the Philips USA website.

أقر بذلك

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.